At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the efficacy of modern medicines often depends on the quality of their precursor materials. Methyl 4-(Bromomethyl)-3-Methoxybenzoate, cataloged under CAS number 70264-94-7, is a prime example of such a critical pharmaceutical intermediate. Its primary application in the synthesis of Zafirlukast, a cornerstone medication for asthma management, highlights its immense value in the healthcare sector and the broader fine chemical industry. This article explores the properties and impact of this essential chemical compound.

The compound is characterized by its physical form as a white to off-white crystalline powder, indicative of its high purity, a standard that is non-negotiable in pharmaceutical applications. With a molecular formula of C10H11BrO3 and a molecular weight of 259.096, it offers predictable reactivity essential for intricate organic synthesis. An assay of ≥98.0% for this compound underscores its suitability for demanding processes like Zafirlukast intermediate synthesis, ensuring that the final drug product meets stringent quality benchmarks.

The pivotal role of Methyl 4-(Bromomethyl)-3-Methoxybenzoate is its function as a key intermediate in the production of Zafirlukast. Zafirlukast is a selective leukotriene receptor antagonist that has proven highly effective in managing chronic asthma. By inhibiting the action of leukotrienes, which are inflammatory substances that constrict airways and increase mucus production, Zafirlukast provides relief and improves respiratory function for asthma patients. The bromomethyl group present in Methyl 4-(Bromomethyl)-3-Methoxybenzoate is critical for facilitating the chemical transformations necessary to assemble the Zafirlukast molecule, firmly establishing it as a crucial asthma medication intermediate.

The global demand for reliable pharmaceutical supplies necessitates consistent access to high-quality intermediates. NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in this supply chain by ensuring the availability of high purity methyl 4-(bromomethyl)-3-methoxybenzoate. Manufacturers worldwide depend on the consistent quality of this pharmaceutical intermediate chemical for their critical Zafirlukast intermediate synthesis. This dependability is essential for maintaining the production of life-saving medications.

Beyond its direct use in drug manufacturing, Methyl 4-(Bromomethyl)-3-Methoxybenzoate also serves as a valuable compound in general organic synthesis and research. Its chemical structure and reactivity make it useful for exploring new synthetic routes and developing novel compounds. The availability of reliable fine chemical CAS 70264-94-7 supports innovation across various chemical disciplines. The consistent supply of such intermediates is a hallmark of advanced chemical manufacturing capabilities.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to advancing healthcare through the provision of high-quality chemical intermediates. Our expertise ensures that clients receive compounds that meet rigorous standards for pharmaceutical production. For detailed information on Zafirlukast intermediate synthesis, custom chemical manufacturing, or our comprehensive range of pharmaceutical intermediates, we invite you to connect with us. We are dedicated to being your trusted partner in chemical sourcing and innovation.